Amprologix Celebrates Research Excellence at the University of…
7 November 2025Amprologix celebrates research excellence at the University of Plymouth as CSO Professor Mat Upton presents the Research Excellence Award to…
Amprologix celebrates research excellence at the University of Plymouth as CSO Professor Mat Upton presents the Research Excellence Award to…
Amprologix has raised £740,000 to accelerate the development of our breakthrough antibiotic Epidermicin NI01. This investment also supports our AI-driven…
We are pleased to announce that Professor Mat Upton, Chief Scientific Officer at Amprologix, will represent the company at the…
This summer we’ve been pleased to welcome Rutendo Mupfumi from the University of Plymouth to the Amprologix lab. As part…
Amprologix joins a global network of innovators We're proud to announce that Amprologix is one of the 103 finalists selected…
We are pleased to announce that Professor Mat Upton, Chief Scientific Officer at Amprologix, will represent the company at the upcoming LSX World Congress in Boston, MA, USA
Mat Upton, CSO, presented the latest results from ongoing research at ESCMID Global 2025. ESCMID Global 2025 - the Congress of the European Society of Clinical Microbiology and Infectious Diseases - ran from April 11-15 in Vienna, and was attended by an audience of leading experts in infectious diseases and clinical microbiology. Amprologix presented results from […]
Mat Upton, CSO, presented new data at the 9th AMR conference in Basel on 25th February. It was suggested that probably half the global antimicrobial R&D activity was represented by attendees in the room. In a recent robust skin infection model with MRSA strain USA300, data demonstrate that a single daily dose of lead antibiotic […]
